Amr Abdelhamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amr Abdelhamed has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Devon J. Hensel
Division of Adolescent Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA
2 shared publications - Jacqueline Hendriks
School of Population Health, Curtin University, Perth, Australia
2 shared publications - Jenna Marie Strizzi
University of Almeria
2 shared publications - Jennifer Toller Erausquin
Department of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, United States; Center of Population Sciences for Health Empowerment, Florida State University, Tallahassee, FL, USA
2 shared publications - Maximiliane Uhlich
Faculty of Psychology, University of Basel
2 shared publications - Michael Marks
Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK
2 shared publications
Latest Publications
- 21 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 460
Evaluation of serum and tissue levels of pigment epithelium-derived factor (PEDF) in patients with psoriasis vulgaris
- 21 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 460
Evaluation of serum and tissue levels of pigment epithelium-derived factor (PEDF) in patients with psoriasis vulgaris
- Open Access
- 30 April 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (2) , 6129
Efficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial
Introduction: Emerging evidence suggests that platelet-rich plasma (PRP) has an antifungal role. Objectives: To investigate the efficacy of intralesional PRP in the treatment of fingernail onychomycosis. Patients and Methods: Patients with fingernail onychomycosis were randomized to receive oral terbinafine 250 mg daily for three months, six sessions of intralesional PRP, or both (PRP + terbinafine). Primary outcome of the study was change in onychomycosis severity index (OSI) at the end of follow-up. Two blinded investigators (investigators A and B) assessed the outcomes. The assessment was carried out per affected nail rather than per affected patient. Results: Twenty, 18, and 23 patients were included in the terbinafine, PRP, and terbinafine + PRP groups, respectively, with 40, 51, and 50 nails treated in each respective group. OSI was comparable among study groups according to investigator A (terbinafine: 4 [IQRs: 4, 9], PRP: 6 [IQRs: 2, 12], PRP + terbinafine: 5 [IQRs: 3, 8]; p>0.9) and investigator B (terbinafine: 4 [IQRs: 3, 10], PRP: 6 [IQRs: 4, 10], PRP + terbinafine: 6 [IQRs: 3, 12]; P>0.9). Similarly, mycological cure (terbinafine: 20%, PRP: 35%, PRP + terbinafine: 34%; P=0.23), clinical cure (terbinafine: 23%, PRP: 27%, PRP + terbinafine: 32%; P=0.61), and complete cure (terbinafine: 20%, PRP: 27%, PRP + terbinafine: 28%; P=0.64) were comparable. Conclusions: Six sessions of intralesional PRP were effective in treating fingernail onychomycosis, making it a potential viable alternative for patients who may not respond well to oral antifungal medications or who experience adverse effects from these drugs.
- 30 April 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (2) , 6129
Open AccessEfficacy of Intralesional Platelet-Rich Plasma in Treatment of Fingernail Onychomycosis: A Randomized Controlled Trial
Introduction: Emerging evidence suggests that platelet-rich plasma (PRP) has an antifungal role. Objectives: To investigate the efficacy of intralesional PRP in the treatment of fingernail onychomycosis. Patients and Methods: Patients with fingernail onychomycosis were randomized to receive oral terbinafine 250 mg daily for three months, six sessions of intralesional PRP, or both (PRP + terbinafine). Primary outcome of the study was change in onychomycosis severity index (OSI) at the end of follow-up. Two blinded investigators (investigators A and B) assessed the outcomes. The assessment was carried out per affected nail rather than per affected patient. Results: Twenty, 18, and 23 patients were included in the terbinafine, PRP, and terbinafine + PRP groups, respectively, with 40, 51, and 50 nails treated in each respective group. OSI was comparable among study groups according to investigator A (terbinafine: 4 [IQRs: 4, 9], PRP: 6 [IQRs: 2, 12], PRP + terbinafine: 5 [IQRs: 3, 8]; p>0.9) and investigator B (terbinafine: 4 [IQRs: 3, 10], PRP: 6 [IQRs: 4, 10], PRP + terbinafine: 6 [IQRs: 3, 12]; P>0.9). Similarly, mycological cure (terbinafine: 20%, PRP: 35%, PRP + terbinafine: 34%; P=0.23), clinical cure (terbinafine: 23%, PRP: 27%, PRP + terbinafine: 32%; P=0.61), and complete cure (terbinafine: 20%, PRP: 27%, PRP + terbinafine: 28%; P=0.64) were comparable. Conclusions: Six sessions of intralesional PRP were effective in treating fingernail onychomycosis, making it a potential viable alternative for patients who may not respond well to oral antifungal medications or who experience adverse effects from these drugs.
- Open Access
- 24 June 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (7) , 924
Cold Atmospheric Plasma Enhances TGF-β1, CTGF Protein Expression, and Healing in Full-Thickness Skin Burns: An Animal Study
Cold atmospheric plasma (CAP) interacts with tissues, leading to fast wound disinfection. Given the frequent global burden of burn injuries and the risks of infection associated with acute full-thickness burns (FTBs), this investigation examined CAP as a potential therapeutic method for wound healing due to its antimicrobial and pro-healing effects. Here, we examined the impacts of CAP on the healing of wounds resulting from acute FTSBs. We established an animal model that included four groups: (1) healthy control animals without burns, (2) untreated animals with acute FTSBs, (3) animals with acute FTSBs treated with CAP for 5 s per day for 21 days, and (4) animals with acute FTSBs treated with CAP for 10 s per day for 21 days. Wound healing was assessed using immunohistological methods. In animals with FTSBs, CAP therapy was accompanied by (i) accelerated wound closure, (ii) enhanced regeneration of the dermis and epidermis, and (iii) increased protein expression of transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF). These changes were more pronounced following CAP treatment for 10 s per day compared to CAP treatment for 5 s per day.
- 24 June 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (7) , 924
Open AccessCold Atmospheric Plasma Enhances TGF-β1, CTGF Protein Expression, and Healing in Full-Thickness Skin Burns: An Animal Study
Cold atmospheric plasma (CAP) interacts with tissues, leading to fast wound disinfection. Given the frequent global burden of burn injuries and the risks of infection associated with acute full-thickness burns (FTBs), this investigation examined CAP as a potential therapeutic method for wound healing due to its antimicrobial and pro-healing effects. Here, we examined the impacts of CAP on the healing of wounds resulting from acute FTSBs. We established an animal model that included four groups: (1) healthy control animals without burns, (2) untreated animals with acute FTSBs, (3) animals with acute FTSBs treated with CAP for 5 s per day for 21 days, and (4) animals with acute FTSBs treated with CAP for 10 s per day for 21 days. Wound healing was assessed using immunohistological methods. In animals with FTSBs, CAP therapy was accompanied by (i) accelerated wound closure, (ii) enhanced regeneration of the dermis and epidermis, and (iii) increased protein expression of transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF). These changes were more pronounced following CAP treatment for 10 s per day compared to CAP treatment for 5 s per day.
- Open Access
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4876
Autophagy and Premature Graying of Hair: The Role of LC3 as a Biomarker in a Case-Control Study
Introduction: Premature graying of hair (PGH) is a common disorder with a multifactorial etiology. Autophagy, which is self-cellular digestion, has been linked to melanin pigment formation; however, the role of autophagy in PGH has not been investigated well. Objectives: The study aimed to evaluate the relationship between PGH and autophagy by measuring gene expression and serum LC3 concentration. Methods: A case-control study was conducted on 39 PGH patients and 21 controls. Patients clinically diagnosed with PGH and aged <30 years were included in the study. Blood samples were taken to detect LC3B protein by ELISA in the serum of both groups. White hairs from both groups were collected to detect LC3B gene expression by PCR. Results: There was a statistically significant difference between the 2 groups as regards expression levels of the LC3 gene by PCR (p ˂0.001) with the mean in the control group (0.71± 0.3) lower than in the PGH group (5.1± 1.4). Also, there was a positive significant correlation between LC3 concentration and LC3 gene expression in control (r=0.867, p< 0.001); and in PGH patients (r=0.954, p=< 0.001). Multivariate logistic regression analysis for PGH predictors using the age, sex (female), hemoglobin level, LC3 concentration, and LC3 gene expression revealed that the only predictor of PGH was LC3 gene expression. Conclusions: Premature graying of hair might have a link with autophagy. LC3 gene expression was increased in PGH patients as compared to the control. LC3 gene expression might be an independent predictor of PGH development.
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4876
Open AccessAutophagy and Premature Graying of Hair: The Role of LC3 as a Biomarker in a Case-Control Study
Introduction: Premature graying of hair (PGH) is a common disorder with a multifactorial etiology. Autophagy, which is self-cellular digestion, has been linked to melanin pigment formation; however, the role of autophagy in PGH has not been investigated well. Objectives: The study aimed to evaluate the relationship between PGH and autophagy by measuring gene expression and serum LC3 concentration. Methods: A case-control study was conducted on 39 PGH patients and 21 controls. Patients clinically diagnosed with PGH and aged <30 years were included in the study. Blood samples were taken to detect LC3B protein by ELISA in the serum of both groups. White hairs from both groups were collected to detect LC3B gene expression by PCR. Results: There was a statistically significant difference between the 2 groups as regards expression levels of the LC3 gene by PCR (p ˂0.001) with the mean in the control group (0.71± 0.3) lower than in the PGH group (5.1± 1.4). Also, there was a positive significant correlation between LC3 concentration and LC3 gene expression in control (r=0.867, p< 0.001); and in PGH patients (r=0.954, p=< 0.001). Multivariate logistic regression analysis for PGH predictors using the age, sex (female), hemoglobin level, LC3 concentration, and LC3 gene expression revealed that the only predictor of PGH was LC3 gene expression. Conclusions: Premature graying of hair might have a link with autophagy. LC3 gene expression was increased in PGH patients as compared to the control. LC3 gene expression might be an independent predictor of PGH development.
- 17 April 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 25 (3) , 767-773
The Superficial Lesions in the Periauricular Region: A Retrospective Study
Objective Superficial lesions on and around the ear are uncommon with broad differential diagnoses and different characteristic histopathologic features. Most of these lesions may have similar clinical and structural features resulting in obstacles in clinical diagnosis. The purpose of this study was to describe a series of periauricular superficial lesions and characterize the distinctive types of these lesions. Study Design A retrospective study. Setting A tertiary care center. Methods Between 2019 and early 2023, a descriptive retrospective study, including 120 patients who presented with periauricular superficial lesions, was conducted. Results Preauricular lesions were the most frequent (49.2%), followed by postauricular lesions (33.3%). As regards the etiological patterns of the patients, congenital causes were the most frequent (45%), followed by neoplastic lesions (40.8%). 37.5% of cases were preauricular sinus followed by epidermoid cyst (21.7%) and reactive lymphoid hyperplasia (6.7%). Conclusions There is great diversity in patterns and etiological causes of periauricular lesions. The congenital etiology is the most common cause of periauricular lesions. An individualized approach based on the nature and etiology of the lesion allows for more accurate diagnosis and treatment planning.
- 17 April 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 25 (3) , 767-773
The Superficial Lesions in the Periauricular Region: A Retrospective Study
Objective Superficial lesions on and around the ear are uncommon with broad differential diagnoses and different characteristic histopathologic features. Most of these lesions may have similar clinical and structural features resulting in obstacles in clinical diagnosis. The purpose of this study was to describe a series of periauricular superficial lesions and characterize the distinctive types of these lesions. Study Design A retrospective study. Setting A tertiary care center. Methods Between 2019 and early 2023, a descriptive retrospective study, including 120 patients who presented with periauricular superficial lesions, was conducted. Results Preauricular lesions were the most frequent (49.2%), followed by postauricular lesions (33.3%). As regards the etiological patterns of the patients, congenital causes were the most frequent (45%), followed by neoplastic lesions (40.8%). 37.5% of cases were preauricular sinus followed by epidermoid cyst (21.7%) and reactive lymphoid hyperplasia (6.7%). Conclusions There is great diversity in patterns and etiological causes of periauricular lesions. The congenital etiology is the most common cause of periauricular lesions. An individualized approach based on the nature and etiology of the lesion allows for more accurate diagnosis and treatment planning.
- 3 July 2023
- Published by Taylor & Francis in International Journal of Sexual Health
- Vol. 35 (3) , 459-480
Changes in Solo and Partnered Sexual Behaviors following the First COVID-19 Wave: Data from an International Study of 26 Countries
- 3 July 2023
- Published by Taylor & Francis in International Journal of Sexual Health
- Vol. 35 (3) , 459-480
Changes in Solo and Partnered Sexual Behaviors following the First COVID-19 Wave: Data from an International Study of 26 Countries
- Open Access
- 9 April 2022
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 89 (2) , 195-203
Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial
Background: Chronic telogen effluvium is characterised by diffuse loss of hair of the scalp. One of the emerging lines of treatment is platelet-rich plasma. However, not much of published data exist.Aims: A pilot study was conducted on chronic telogen effluvium patients to evaluate the efficacy and safety of platelet-rich plasma, and to compare two different methods of platelet-rich plasma preparation.Methods: The study included 30 female patients with chronic telogen effluvium. Patients were randomised into three groups: Group (1): Special platelet-rich plasma tubes centrifuged at 3500 rpm; Group (2): Ordinary laboratory tubes centrifuged at 1000 rpm; Group (3): Normal saline as a placebo. Patients' evaluation was done with visual analog scale, hair pull test, trichoscopy, photos, satisfaction questionnaire, and safety. All patients received four monthly sessions. Patients were evaluated one month and three months after the last session.Results: The hair pull test,visual analogue scale, and patient satisfaction results showed a statistically significant difference between group 1 vs. group 3 and group 2 vs.group 3 at one and three months after the sessions, while there was no difference between group1 vs. group 2. Trichoscopy results (baseline, one and three months after treatment) showed a significant increase in hair density and thickness in the frontal area, temporal area, and the vertex in groups 1 and 2 only. There was no statistically significant difference between the three groups with regards to side effects.Limitations: The sample size was small with ten patients in each group. Furthermore, the follow-up of patients was for only three months.Conclusions: Platelet-rich plasma could be considered as a promising therapy for patients with chronic telogen effluvium with an excellent safety profile. The ordinary laboratory low-cost tubes might be a reliable alternative to the expensive special platelet-rich plasma kits tubes. The trial registry number is PACTR202006539654415.
- 9 April 2022
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 89 (2) , 195-203
Open AccessEvaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial
Background: Chronic telogen effluvium is characterised by diffuse loss of hair of the scalp. One of the emerging lines of treatment is platelet-rich plasma. However, not much of published data exist.Aims: A pilot study was conducted on chronic telogen effluvium patients to evaluate the efficacy and safety of platelet-rich plasma, and to compare two different methods of platelet-rich plasma preparation.Methods: The study included 30 female patients with chronic telogen effluvium. Patients were randomised into three groups: Group (1): Special platelet-rich plasma tubes centrifuged at 3500 rpm; Group (2): Ordinary laboratory tubes centrifuged at 1000 rpm; Group (3): Normal saline as a placebo. Patients' evaluation was done with visual analog scale, hair pull test, trichoscopy, photos, satisfaction questionnaire, and safety. All patients received four monthly sessions. Patients were evaluated one month and three months after the last session.Results: The hair pull test,visual analogue scale, and patient satisfaction results showed a statistically significant difference between group 1 vs. group 3 and group 2 vs.group 3 at one and three months after the sessions, while there was no difference between group1 vs. group 2. Trichoscopy results (baseline, one and three months after treatment) showed a significant increase in hair density and thickness in the frontal area, temporal area, and the vertex in groups 1 and 2 only. There was no statistically significant difference between the three groups with regards to side effects.Limitations: The sample size was small with ten patients in each group. Furthermore, the follow-up of patients was for only three months.Conclusions: Platelet-rich plasma could be considered as a promising therapy for patients with chronic telogen effluvium with an excellent safety profile. The ordinary laboratory low-cost tubes might be a reliable alternative to the expensive special platelet-rich plasma kits tubes. The trial registry number is PACTR202006539654415.
- Open Access
The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave
Background The COVID-19 pandemic forced billions of people to shelter in place, altering social and sexual relationships worldwide. In many settings, COVID-19 threatened already precarious health services. However, there is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of COVID-19 disease. To address this gap, our team organized a multi-country, cross-sectional online survey as part of a global consortium. Methods Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service utilization, and we compared three months prior to and three months after policy measures to mitigate COVID-19. We used established indicators and analyses pre-specified in our protocol. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence using Cochrane methods. Descriptive analyses included 22,724 individuals in 25 countries. Five additional countries with sample sizes Results Respondents were mean age 34 years; most identified as women (15160; 66.7%), cis-gender (19432; 86.6%) and heterosexual (16592; 77.9%). Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%) people and 640 (14.1%) people reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063/15144, 7.0%) compared to the period before COVID-19 measures (1469/15887, 9.3%). COVID-19 measures impeded access to condoms (933/10790, 8.7%), contraceptives (610/8175, 7.5%), and HIV/STI testing (750/1965, 30.7%). Pooled estimates from meta-analysis indicate during COVID-19 measures, 32.3% (95% CI 23.9-42.1) of people needing HIV/STI testing had hindered access, 4.4% (95% CI 3.4-5.4) experienced partner violence, and 5.8% (95% CI 5.4-8.2) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy. Conclusion Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.
Open AccessThe International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave
Background The COVID-19 pandemic forced billions of people to shelter in place, altering social and sexual relationships worldwide. In many settings, COVID-19 threatened already precarious health services. However, there is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of COVID-19 disease. To address this gap, our team organized a multi-country, cross-sectional online survey as part of a global consortium. Methods Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service utilization, and we compared three months prior to and three months after policy measures to mitigate COVID-19. We used established indicators and analyses pre-specified in our protocol. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence using Cochrane methods. Descriptive analyses included 22,724 individuals in 25 countries. Five additional countries with sample sizes Results Respondents were mean age 34 years; most identified as women (15160; 66.7%), cis-gender (19432; 86.6%) and heterosexual (16592; 77.9%). Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%) people and 640 (14.1%) people reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063/15144, 7.0%) compared to the period before COVID-19 measures (1469/15887, 9.3%). COVID-19 measures impeded access to condoms (933/10790, 8.7%), contraceptives (610/8175, 7.5%), and HIV/STI testing (750/1965, 30.7%). Pooled estimates from meta-analysis indicate during COVID-19 measures, 32.3% (95% CI 23.9-42.1) of people needing HIV/STI testing had hindered access, 4.4% (95% CI 3.4-5.4) experienced partner violence, and 5.8% (95% CI 5.4-8.2) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy. Conclusion Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.
- 1 September 2021
- Published by Elsevier in Reproductive Toxicology
- Vol. 104, 85-95
The impact of isotretinoin on the pituitary-ovarian axis: An interpretative review of the literature
- 1 September 2021
- Published by Elsevier in Reproductive Toxicology
- Vol. 104, 85-95
The impact of isotretinoin on the pituitary-ovarian axis: An interpretative review of the literature
- Open Access
- 1 December 2020
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 13, 1005-1013
Assessment of the Effect of Metabolic Syndrome on the Autophagy Marker LC3 in Psoriasis Vulgaris Patients: A Cross-Sectional Study
Purpose: Psoriasis vulgaris, one of the most prevalent chronic inflammatory skin diseases, is associated with metabolic syndrome (MetS). Autophagy, an intracellular degradation system is essential for cell survival and differentiation, and its dysfunction may contribute to metabolic diseases. A cross-sectional study was conducted on 38 psoriasis vulgaris patients and 16 healthy control subjects to 1) Assess immunohistochemical (IHC) expression of microtubule-associated protein light chain 3 (LC3); 2) Evaluate the relationship between Psoriasis Area Severity Index (PASI) score, and LC3 expression. Patients and Methods: PASI score was evaluated for all psoriasis patients. Lipid profile, blood sugar, and CRP were done for all patients and controls. A punch biopsy was taken from lesional and perilesional skin of psoriasis patients and normal skin of the controls. Tissue sections were prepared. IHC LC3 staining was done and evaluated. Results: LC3 was nearly absent, in the epidermis of the lesional skin of psoriasis while it was strong among control (p=0.001). LC3 expression in the lesional skin of psoriasis vulgaris was lower than its expression in perilesional (p=0.001). However, LC3 expression was not significantly changed with PASI or the presence/absence of MetS. Conclusion: A potential link between psoriasis vulgaris and autophagy as assessed by LC3 could be present. LC3 was down-regulated in psoriasis lesions than in normal skin. However, its expression did not change with PASI or MetS. An autophagy enhancer might be used as a possible therapeutic target in psoriasis vulgaris patients.
- 1 December 2020
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 13, 1005-1013
Open AccessAssessment of the Effect of Metabolic Syndrome on the Autophagy Marker LC3 in Psoriasis Vulgaris Patients: A Cross-Sectional Study
Purpose: Psoriasis vulgaris, one of the most prevalent chronic inflammatory skin diseases, is associated with metabolic syndrome (MetS). Autophagy, an intracellular degradation system is essential for cell survival and differentiation, and its dysfunction may contribute to metabolic diseases. A cross-sectional study was conducted on 38 psoriasis vulgaris patients and 16 healthy control subjects to 1) Assess immunohistochemical (IHC) expression of microtubule-associated protein light chain 3 (LC3); 2) Evaluate the relationship between Psoriasis Area Severity Index (PASI) score, and LC3 expression. Patients and Methods: PASI score was evaluated for all psoriasis patients. Lipid profile, blood sugar, and CRP were done for all patients and controls. A punch biopsy was taken from lesional and perilesional skin of psoriasis patients and normal skin of the controls. Tissue sections were prepared. IHC LC3 staining was done and evaluated. Results: LC3 was nearly absent, in the epidermis of the lesional skin of psoriasis while it was strong among control (p=0.001). LC3 expression in the lesional skin of psoriasis vulgaris was lower than its expression in perilesional (p=0.001). However, LC3 expression was not significantly changed with PASI or the presence/absence of MetS. Conclusion: A potential link between psoriasis vulgaris and autophagy as assessed by LC3 could be present. LC3 was down-regulated in psoriasis lesions than in normal skin. However, its expression did not change with PASI or MetS. An autophagy enhancer might be used as a possible therapeutic target in psoriasis vulgaris patients.